Salvage Therapy for Prostate Cancer - Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy

Publication Date: February 14, 2024
Last Updated: February 29, 2024

Summary of Recommendations

Clinicians should offer androgen deprivation therapy (ADT) in addition to salvage RT for patients with BCR following RP and any high-risk features (e.g., higher post-prostatectomy PSA such as PSA ≥0.7ng/mL, Gleason Grade Group 4 to 5, PSADT ≤6months, persistently detectable post-operative PSA, seminal vesicle involvement). (Moderate, B)
322859

Overview

Title

Salvage Therapy for Prostate Cancer - Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy

Authoring Organizations